scPharmaceuticals (SCPH) Company Sales Revenue

Volatility in the aggregate sales figures of scPharmaceuticals Inc. (SCPH) is driven by the expansion of the Furoscix system for home treatment of heart failure. Stability is supported by the implementation of closed-loop water cycles in production and a strategic focus on the US domestic market. The current value of the indicator is 0.05, which allows for an assessment of the business's fundamental base and the demand for the issuer's medical innovations.

scpharmaceuticals.com (SCPH) Revenue and Sales Volume: for the period 07/04/2022 - 10/18/2025

Comprehensive metric breakdowns and analytics for scpharmaceuticals.com (SCPH)

- market price and analyst price targets:

Market Price scpharmaceuticals.com|SCPH - Price Target Chart

- market capitalization details:

Market Value scPharma|SCPH - Total Company Value

- balance sheet net asset value indicators:

Net Assets per Share scPharmaceuticals|SCPH - Book Capitalization|Market Cap to Net Assets Ratio scpharmaceuticals.com|SCPH - Aggregate Company Assets

- company liabilities and liquidity data:

Aggregate Debt to Equity scPharmaceuticals Inc.|SCPH - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital scPharmaceuticals Inc.|SCPH - Company Aggregate Debts|Debts to Book Capitalization scPharma|SCPH - Company Long-Term Debt|Company Short-Term Loans and Borrowings scPharmaceuticals|Quick Liquidity Indicator scpharmaceuticals.com

- earnings and market multiples details:

SCPH - Net Profit|Projected Future Earnings scPharmaceuticals Inc.|SCPH - P/E Multiple|Projected Price to Earnings scPharmaceuticals Inc.|SCPH - PEG Multiple|Company Value to EBITDA scPharmaceuticals Inc.|SCPH - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) scPharmaceuticals|SCPH - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months scpharmaceuticals.com|SCPH - Earnings growth in current year|Consensus forecast of earnings per share growth for next year scPharmaceuticals Inc.

- company sales and revenue statistics:

SCPH - Revenue and Sales Volume|Company Future Sales Volume scPharmaceuticals Inc.|SCPH - P/S Multiple|Forward P/S Multiple scPharma|SCPH - Sales Growth YoY (Last Twelve Months)

Summary company analysis:SCPH, scPharmaceuticals, Inc.

Manufactured products of scPharmaceuticals Inc.

Finding a balance between intrinsic value and market price requires an analysis of cash flow stability. This indicator captures the daily volume of actual sales, making it possible to identify abnormal deviations from average revenue. For scPharmaceuticals Inc. (SCPH), such granularity is critical due to its dependence on global supplies of cardiac medications. The risks of supply chain disruptions are reflected in the volatility of the company's commercial sales volumes. The dynamics of these metrics help investors assess the business's resilience to geopolitical shocks.

Analysis of competing companies